Source / episode info
- **Episode:**360
- **Title:**Divine Intervention Episode 360 – The Clutch Secondary Hypertension Podcast (Step 1-3)
- **Published:**2022-01-03
- Source:Episode page
One-liner
This episode provides a comprehensive review of secondary causes of hypertension, integrating concepts from renal physiology (RAS workup), endocrinology (Conn syndrome, Cushing's), and genetics (MEN syndromes) to prepare students for complex board-style clinical vignettes.
High-yield summary
- Renal Artery Stenosis (RAS): The hallmark is secondary hyperaldosteronism due to reduced renal perfusion activating the RAAS system; a key pitfall is avoiding ACE inhibitors/ARBs in bilateral RAS.
- Primary Hyperaldosteronism (Conn Syndrome): Characterized by resistant hypertension, hypokalemia, and metabolic alkalosis; diagnosis relies on an elevated Plasma Aldosterone to Plasma Renin Ratio (ARR) > 30 and failure of aldosterone suppression after saline infusion.
- Cushing's Syndrome: Excess cortisol acts as a mineralocorticoid agonist, leading to sodium/water retention, potassium wasting, hypertension, hypokalemia, and metabolic alkalosis.
- MEN2 Syndrome: The classic triad includes Medullary Thyroid Cancer (MTC), Pheochromocytoma, and Primary Hyperparathyroidism; the catecholamine excess from pheo is a major cause of HTN.
- RAS Differential Diagnosis: Atherosclerosis affects the intima layer, while Fibromuscular Dysplasia (FMD) typically affects the media layer.
- Acute Care/Trauma: Increased Intracranial Pressure (ICP) can trigger Cushing's Triad (Hypertension, Bradycardia, Irregular Respirations) due to CRH release.
Learning objectives
- Differentiate the pathophysiology and diagnostic workup for primary vs. secondary hypertension.
- Identify the specific anatomical differences between atherosclerotic RAS (intima) and fibromuscular dysplasia (media).
- Recognize the classic clinical triad, associated hormones, and genetic basis of MEN2 syndrome.
- Interpret laboratory findings (e.g., Aldosterone/Renin ratio, urinary electrolytes) to diagnose mineralocorticoid excess states.
- Apply knowledge of endocrine axes (HPA axis, RAAS) in acute settings (e.g., increased ICP).